Transcription factor 7-like 2 as type-2 diabetes mellitus diagnostic marker in ethnic Minangkabau

Main Article Content

Syamsurizal Syamsurizal
Yanwirasti Yanwirasti
Asman Manaf
Jamsari Jamsari
ML Edy Parwanto
Arif Sardi


The prevalence of type-2 diabetes mellitus (T2DM) has been increasing rapidly in developed and developing countries. Many new loci associated with T2DM have been uncovered by genetic and genome-wide association studies, eg. the transcription factor 7-like 2 (TCF7L2) gene variant rs7895340 has been associated with type-2 diabetes mellitus. The aim of this research was to find an association between polymorphisms of TCF7L2 gene variant rs7895340 with T2DM in ethnic Minangkabau.

This was a case-control study using a consecutive sampling technique among ethnic Minangkabau patients who came for treatment to the Metabolic Endocrinology Polyclinic at Dr. M. Jamil Hospital. Analysis was performed on 132 subjects (66 T2DM patients and 66 controls). DNA was isolated from venous blood samples and amplified using the amplification refractory mutation system - polymerase chain reaction (ARMS-PCR) method to detect single nucleotide polymorphisms (SNPs) of TCF7L2 gene variant rs7895340. To determine the significance of association of SNPs of rs7895340 with T2DM in ethnic Minangkabau, data analysis was performed using chi-square test.

The ARMS - PCR for TCF7L2 gene variant rs7895340 found polymorphisms in 28 (42.42%) subjects with type 2 diabetes mellitus and in 15 (22.72%) non-diabetic subjects.There was a significant association between rs7895340 SNPs with the probability of T2DM in ethnic Minangkabau (OR=2.505, p=0.026).

Single nucleotide polymorphism rs7895340 of TCF7L2 gene can be used as genetic marker of type-2 diabetes mellitus in ethnic Minangkabau.

Article Details

How to Cite
Syamsurizal, S., Yanwirasti, Y., Manaf, A., Jamsari, J., Parwanto, M. E., & Sardi, A. (2014). Transcription factor 7-like 2 as type-2 diabetes mellitus diagnostic marker in ethnic Minangkabau. Universa Medicina, 33(3), 205–212.
Review Article


American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimate for the year 2000 and projection for 2030. Diabetes Care 2004;27:1047-53.

American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36 Suppl 1:S11-66.

Negrato CA, Dias JP, Teixeira MF, Dias A, Salgado MH, Lauris JR, et al. Temporal trends in incidence of type 1 diabetes between 1986 and 2006 in Brazil. J Endocrinol Investig 2010;33: 373-7.

Perkumpulan Endokrinologi Indonesia. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: Pengurus Besar Perkumpulan Endokrinologi Indonesia; 2011.

Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009;53:S35-42.

Kemp TM, Barr ELM, Zimmet PZ, Cameron AJ, Welborn TA, Colagiuri S, et al. Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes. Diabetes Care 2005; 28:1490-2.

Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46: 760-5.

Radha V, Mohan V. Genetic predisposition to type 2 diabetes mellitus among Asian Indians. Indian J Med Res 2007;117:259-74.

Stolerman ES, Manning AK, McAteer JB, Fox CS, Dupuis J, Meigs JB, et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009;52:614-20.

Chang YC, Chiu YF, Ho LLT, Ting CT, Shih KC, Curb JD, et al. TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance. J Mol Med 2010; 33:183-02.

Wu SHL, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARg and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009;24: 3360–6.

National Center for Biotechnology Information, U.S. National Library of Medicine. Transcription factor 7 like 2 gen T-cell specific, HMG-box [Homo sapiens (human)]; 2014. Available at: Accessed June 6, 2014.

Florez JC, Jablonski KA, Bayle N, Pollin TI, Bakker PIW, Shuldiner AR, et al. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006;355:241-50.

Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-3.

Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian klinis. Jakarta: Sagung Seto;2010.

Dieffenbach CW, Dveksler GS, editors. PCR primer: a laboratory manual. 2nd edition. New York: Cold Spring Harbor Laboratory Press; 2003.

Peng S, Zhu Y, Lu B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121174 subjects. Mutagenesis 2013; 28:25-37.

Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006;55:2649-53.

Nelson WJ and Nusse R. Convergence of wnt, b-catenin, and cadherin pathways. Science 2004; 303:1483–7.

Jin T. The wnt signalling pathway and diabetes mellitus. Diabetologia 2008;51:1771-80.

Smith U. TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia 2007;50:5-7.